Advanced search
1 file | 847.12 KB Add to list

Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model

Author
Organization
Keywords
prolyl hydroxylase containing domain, vascular endothelial growth factor, placental growth factor, biliary tumours, angiogenesis, HUMAN INTRAHEPATIC CHOLANGIOCARCINOMA, ANGIOGENESIS, EXPRESSION, CANCER, LIVER, TRANSPLANTATION, PROGRESSION, SORAFENIB, SURVIVAL, RECEPTOR

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 847.12 KB

Citation

Please use this url to cite or link to this publication:

MLA
Heindryckx, Femke, et al. “Inhibition of the Placental Growth Factor Decreases Burden of Cholangiocarcinoma and Hepatocellular Carcinoma in a Transgenic Mouse Model.” EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, vol. 24, no. 9, 2012, pp. 1020–32, doi:10.1097/MEG.0b013e3283554219.
APA
Heindryckx, F., Bogaerts, E., Coulon, S., Devlies, H., Geerts, A., Libbrecht, L., … Van Vlierberghe, H. (2012). Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 24(9), 1020–1032. https://doi.org/10.1097/MEG.0b013e3283554219
Chicago author-date
Heindryckx, Femke, Eliene Bogaerts, Stephanie Coulon, Hilde Devlies, Anja Geerts, Louis Libbrecht, Jean Marie Stassen, Peter Carmeliet, Isabelle Colle, and Hans Van Vlierberghe. 2012. “Inhibition of the Placental Growth Factor Decreases Burden of Cholangiocarcinoma and Hepatocellular Carcinoma in a Transgenic Mouse Model.” EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 24 (9): 1020–32. https://doi.org/10.1097/MEG.0b013e3283554219.
Chicago author-date (all authors)
Heindryckx, Femke, Eliene Bogaerts, Stephanie Coulon, Hilde Devlies, Anja Geerts, Louis Libbrecht, Jean Marie Stassen, Peter Carmeliet, Isabelle Colle, and Hans Van Vlierberghe. 2012. “Inhibition of the Placental Growth Factor Decreases Burden of Cholangiocarcinoma and Hepatocellular Carcinoma in a Transgenic Mouse Model.” EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 24 (9): 1020–1032. doi:10.1097/MEG.0b013e3283554219.
Vancouver
1.
Heindryckx F, Bogaerts E, Coulon S, Devlies H, Geerts A, Libbrecht L, et al. Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2012;24(9):1020–32.
IEEE
[1]
F. Heindryckx et al., “Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model,” EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, vol. 24, no. 9, pp. 1020–1032, 2012.
@article{3053684,
  author       = {{Heindryckx, Femke and Bogaerts, Eliene and Coulon, Stephanie and Devlies, Hilde and Geerts, Anja and Libbrecht, Louis and Stassen, Jean Marie and Carmeliet, Peter and Colle, Isabelle and Van Vlierberghe, Hans}},
  issn         = {{0954-691X}},
  journal      = {{EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY}},
  keywords     = {{prolyl hydroxylase containing domain,vascular endothelial growth factor,placental growth factor,biliary tumours,angiogenesis,HUMAN INTRAHEPATIC CHOLANGIOCARCINOMA,ANGIOGENESIS,EXPRESSION,CANCER,LIVER,TRANSPLANTATION,PROGRESSION,SORAFENIB,SURVIVAL,RECEPTOR}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{1020--1032}},
  title        = {{Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model}},
  url          = {{http://doi.org/10.1097/MEG.0b013e3283554219}},
  volume       = {{24}},
  year         = {{2012}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: